By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Abbott today reported that its second-quarter molecular diagnostics sales increased around 19 percent year over year.

The firm posted total molecular diagnostics sales of $105 million for the three-month period ended June 30, compared to $89 million for Q2 2010. Of the $105 million, $45 million of the sales came from the US with the remainder coming from international markets.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The new Riken president outlines some of his plans for the institute.

The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.

An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.

In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.